New York State Common Retirement Fund’s Accelerate Diagnostics AXDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-27
Closed 3278
2022
Q2
$0 Sell
27
-1,540
-98% -$13.6K ﹤0.01% 3474
2022
Q1
$23K Buy
1,567
+2
+0.1% +$57 ﹤0.01% 3279
2021
Q4
$82K Buy
1,565
+770
+97% +$42.9K ﹤0.01% 3129
2021
Q3
$46K Sell
795
-1,675
-68% -$109K ﹤0.01% 3253
2021
Q2
$199K Buy
2,470
+30
+1% +$2.38K ﹤0.01% 3045
2021
Q1
$203K Hold
2,440
﹤0.01% 2828
2020
Q4
$185K Sell
2,440
-540
-18% -$48.4K ﹤0.01% 2788
2020
Q3
$318K Hold
2,980
﹤0.01% 2438
2020
Q2
$452K Buy
2,980
+780
+35% +$76.9K ﹤0.01% 2272
2020
Q1
$183K Hold
2,200
﹤0.01% 2501
2019
Q4
$372K Sell
2,200
-590
-21% -$97.4K ﹤0.01% 2443
2019
Q3
$518K Hold
2,790
﹤0.01% 2312
2019
Q2
$638K Hold
2,790
﹤0.01% 2244
2019
Q1
$586K Hold
2,790
﹤0.01% 2233
2018
Q4
$321K Hold
2,790
﹤0.01% 2487
2018
Q3
$640K Hold
2,790
﹤0.01% 2311
2018
Q2
$622K Hold
2,790
﹤0.01% 2356
2018
Q1
$638K Hold
2,790
﹤0.01% 2249
2017
Q4
$731K Hold
2,790
﹤0.01% 2193
2017
Q3
$626K Sell
2,790
-1,033
-27% -$254K ﹤0.01% 2252
2017
Q2
$1.04M Buy
3,823
+1,403
+58% +$380K ﹤0.01% 2016
2017
Q1
$586K Hold
2,420
﹤0.01% 2315
2016
Q4
$502K Hold
2,420
﹤0.01% 2366
2016
Q3
$660K Hold
2,420
﹤0.01% 2181
2016
Q2
$348K Sell
2,420
-1,490
-38% -$200K ﹤0.01% 2447
2016
Q1
$562K Buy
3,910
+1,830
+88% +$258K ﹤0.01% 2205
2015
Q4
$447K Sell
2,080
-1,051
-34% -$192K ﹤0.01% 2378
2015
Q3
$507K Buy
3,131
+753
+32% +$163K ﹤0.01% 2314
2015
Q2
$614K Buy
+2,378
New +$568K ﹤0.01% 2423

Other funds holding AXDX

New York State Common Retirement Fund's AXDX Position: Q3 2022 in Review

New York State Common Retirement Fund sold out of Accelerate Diagnostics (AXDX) in Q3 2022, closing a stake of 27 shares.

New York State Common Retirement Fund first reported a position in AXDX in Q2 2015 and held it in 29 quarters. The position peaked at $1.04M in Q2 2017. 84 funds tracked by Wall St. Rank hold AXDX as of Q3 2022.

  • New York State Common Retirement Fund reported no remaining Accelerate Diagnostics position as of Q3 2022 after selling out during the quarter.
  • New York State Common Retirement Fund sold 27 Accelerate Diagnostics shares in Q3 2022.
  • New York State Common Retirement Fund first reported a position in Accelerate Diagnostics in Q2 2015 and held it in 29 quarters.
  • New York State Common Retirement Fund's Accelerate Diagnostics position peaked at $1.04M in Q2 2017.
  • 84 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q3 2022.

Based on New York State Common Retirement Fund's 13F filing for Q3 2022, filed 8 Nov 2022.